Sign in
Taking people in United StatesNo phase

Tests a video game for attention problems in childhood cancer survivors

Tests a video game against a control game in childhood leukemia or brain tumor survivors.

Key facts

Who runs it
Children's National Research Institute
Where
Washington D.C., United StatesSee the site
Trial code
Registry title
Feasibility/Acceptability of Attentional-Control Training in Survivors
Status
Recruiting
People taking part
50 people, planned
Started
14 Jun 2023
Planned end
31 Aug 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • EndeavorRx
  • Control video game
Record updated
10 January 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children aged 8-16 who had acute lymphoblastic leukemia or a brain tumor and finished treatment at least 1 year ago. It tests a computer-based attention training.

Age
8-16 years
Sex
Boys and girls
Disease stage
History of acute lymphoblastic leukemia (ALL) or brain tumor. At least 1 year after the end of planned therapy, with the disease stable.
Earlier treatment
Not taking stimulant medication for attention problems, or on a stable dose for at least 30 days before joining.
Biomarker or test result
To be randomized, a child needs a T-score of 75th percentile or higher on the CPT-3 Omission Errors scale or the BRIEF-2 Cognitive Regulation Index.

Main reasons for not taking part

  • History of photosensitive seizures
  • Motor, visual, or hearing problem that prevents computer use
  • Mental health condition that blocks or takes priority over the cognitive training
  • Full-scale IQ below 80 (cannot be randomized)
  • Child or caregiver not fluent in spoken English

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Aged 8-16 years at time of screening
  • History of diagnosis of acute lymphoblastic leukemia (ALL) or brain tumor (BT)
  • At least 1 year from completion of planned therapy and stable from a disease standpoint
  • Participating child and caregiver are fluent in spoken English
  • Availability of a caregiver who is willing and capable of providing support and supervision during cognitive training
  • Participating child is either not taking any prescribed stimulant medication for attention difficulties or has been prescribed a stable dose of stimulant medication for attention difficulties for at least 30 days prior to enrollment
  • Only patients with a T-score ≥ 75th percentile on the CPT-3 Omission Errors scale or on the BRIEF-2 Cognitive Regulation Index will be randomized

Who cannot take part

  • A history of photosensitive seizures
  • A mental health condition that precludes, or takes treatment precedence over, participation in the cognitive training
  • A motor, visual, or auditory handicap that prevents computer use
  • Participants identified during the baseline assessment as having a full-scale IQ < 80, as estimated by WASI-II (Vocabulary and Matrix Reasoning), will not be randomized

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 8 and 16 years old?

Where in United States

  • Children's National HospitalWashington D.C., United StatesContact: Steven Hardy, PhDTaking people

About the trial

What the trial wants to find out

This is a multicenter pilot randomized controlled trial, with an active control condition, of the feasibility, acceptability, and preliminary efficacy of EndeavorRx in a cohort of survivors of acute lymphoblastic leukemia or brain tumor ages 8-16 who are > 1 year from the end of therapy.

The 2 groups in the trial

  • EndeavorRxTreatment being tested

    Children will be asked to begin digital attentional control training at home within 6 weeks of baseline testing and to complete 6 training missions per day (25-30 minutes), 5 days per week, for 4 weeks (total = 120 training missions).

  • ControlExisting treatment, for comparison

    An active control program designed to replicate aspects of the intervention (e.g., regular use of digital device to access fun educational activities) while engaging cognitive skills not particularly involving attention.

    Treatment: Control video game

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
FAACTS: Feasibility/Acceptability of Attentional-Control Training in Survivors
Plain-language title
Tests a video game for attention problems in childhood cancer survivorsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05528939, who can take part
Record updated
10 January 2025